Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Taiyo Kuroda"'
Autor:
Chihiro Miyagi, MD, PhD, Taiyo Kuroda, MD, Anthony R. Polakowski, BS, MEng, Christine R. Flick, BS, Shengqiang Gao, PhD, Barry D. Kuban, BS, Jamshid H. Karimov, MD, PhD, Kiyotaka Fukamachi, MD, PhD
Publikováno v:
JHLT Open, Vol 5, Iss , Pp 100118- (2024)
Background: The pediatric continuous-flow total artificial heart (P-CFTAH) is a novel double-ended centrifugal pump designed with the intent to provide circulatory support for pediatric heart failure. To enable continuous monitoring of pump hemodynam
Externí odkaz:
https://doaj.org/article/c6e50d0363104cda884184d2fa61ae3a
Autor:
Jamshid H. Karimov, Chihiro Miyagi, Christine R. Flick, Anthony R. Polakowski, Barry D. Kuban, Taiyo Kuroda, Dennis W. Horvath, Kiyotaka Fukamachi, Randall C. Starling
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
ObjectiveSevere biventricular heart failure (BHF) can be remedied using a biventricular assist device (BVAD). Two devices are currently in development: a universal ventricular assist device (UVAD), which will be able to assist either the left, right,
Externí odkaz:
https://doaj.org/article/17b9b5b097ce4bda82434cd9d488ab42
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2023)
In contrast to the advanced development of the left ventricular assist device (LVAD) therapy for advanced heart failure, the mechanical circulatory support (MCS) with biventricular assist device (BVAD) and total artificial heart (TAH) options remain
Externí odkaz:
https://doaj.org/article/c0bbbd65b22f4f759d9b9ba531f9b588
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
The importance of right heart failure (RHF) treatment is magnified over the years due to the increased risk of mortality. Additionally, the multifactorial origin and pathophysiological mechanisms of RHF render this clinical condition and the choices
Externí odkaz:
https://doaj.org/article/d9be81af70fd4a3aac0b6028a7cb7d81
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
The importance of the left atrium (LA) has been emphasized in recent years as the features of heart failure (HF), especially with regard to variability in patient and pathology phenotypes, continue to be uncovered. Of note, among the population with
Externí odkaz:
https://doaj.org/article/ed718106e32e4ac3bf62d65ba2a68351
Autor:
Taiyo Kuroda, Barry D. Kuban, Takuma Miyamoto, Chihiro Miyagi, Anthony R. Polakowski, Christine R. Flick, Jamshid H. Karimov, Kiyotaka Fukamachi
Publikováno v:
ASAIO Journal.
Autor:
Taiyo Kuroda, Takuma Miyamoto, Chihiro Miyagi, Anthony R. Polakowski, Christine R. Flick, Barry D. Kuban, George B. Voros, Kimberly Such, Kiyotaka Fukamachi, Jamshid H. Karimov
Publikováno v:
Artificial organs. 46(8)
The evaluation of pulsatile flow created by the new Cleveland Clinic continuous-flow total artificial heart (CFTAH100), which has a re-designed right impeller and motor, had not been tested in vivo. The purpose of this study was to evaluate the feasi
Autor:
Taiyo Kuroda, Takuma Miyamoto, Dennis W. Horvath, Chihiro Miyagi, David J. Horvath, Anthony R. Polakowski, Kiyotaka Fukamachi, Jamshid H. Karimov
Publikováno v:
Artificial organsREFERENCES. 46(8)
Despite the advances in the left ventricular assist device (LVAD), there are still situations that require a biventricular assist device (BVAD) system. The purpose of this study was to explore and compare the system performance interactions with the
Autor:
Jun Yokote, Masao Yamada, Masato Yamakawa, Tomio Koyama, Satoshi Yuhara, Masato Mutsuga, Yukifusa Yokoyama, Hiroki Hasegawa, Akihiko Usui, Tetsuya Yamada, Taiyo Kuroda
Publikováno v:
Perfusion. 36:620-625
Introduction: Lactate dehydrogenase (LDH) is widely used as an indicator of pump thrombosis in a centrifugal pump. However, due to the low specificity of LDH, pump thrombosis is difficult to detect in the clinical environment. We measured plasma free
Autor:
Taiyo Kuroda, Kiyotaka Fukamachi, Jamshid H. Karimov, Randall C. Starling, Takuma Miyamoto, Chihiro Miyagi
Publikováno v:
Heart failure reviews. 27(2)
Heart failure with preserved ejection fraction (HFpEF) is characterized by diastolic dysfunction and multiple comorbidities. The number of patients is continuously increasing, with no improvement in its unfavorable prognosis, and there is a strong ne